Docetaxel with Bevacizumab

3 trials

Sponsors

Chiba Tokushukai Hospital, Nihon University School of Medicine, First Department of Internal Medicine,

Conditions

Non-Squamous Non-Small Cell Lung Cancernon-squamous non-small cell lung cancer.

Phase 1

Phase I/II study of Docetaxel with Bevacizumab for refractory and geriatric non-squamous non-small cell lung cancer

Active, not recruitingJPRN-UMIN000006152

Chiba Tokushukai HospitalNon-Squamous Non-Small Cell Lung Cancer

Start: 2011-08-01Target: 20Updated: 2026-06-29

Phase 2

A phase II study of Docetaxel with Bevacizumab for EGFR mutation negative previously treated non-squamous non-small cell lung cancer

Active, not recruitingJPRN-UMIN000006532

Nihon University School of MedicineNon-Squamous Non-Small Cell Lung Cancer

Start: 2011-06-01Target: 30Updated: 2026-06-29

Unknown Phase

A phase II study of Docetaxel with Bevacizumab for previously treated non-squamous non-small cell lung cancer.

Active, not recruitingJPRN-UMIN000008687

First Department of Internal Medicine,non-squamous non-small cell lung cancer.

Start: 2012-08-20Target: 25Updated: 2026-06-29